Sachiko Sweetwood, PHD in La Jolla, CA - Psychologist

Sachiko Sweetwood, PHD is a Psychologist - Clinical based in La Jolla, California. Sachiko Sweetwood is licensed to practice in California (license number PSY30279) and her current practice location is 3252 Holiday Ct Ste 201, La Jolla, California. She can be reached at her office (for appointments etc.) via phone at (858) 534-3755.

NPI number for Sachiko Sweetwood is 1235668963 and her current mailing address is 106 Thorn St, San Diego, California. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1235668963.

Contact Information

	Sachiko Sweetwood, PHD
	3252 Holiday Ct Ste 201, La Jolla, CA 92037-1808
	(858) 534-3755
	Not Available

Healthcare Provider's Profile

Full Name	Sachiko Sweetwood
Gender	Female
Speciality	Psychologist - Clinical
Location	3252 Holiday Ct Ste 201, La Jolla, California
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1235668963
Provider Enumeration Date: 06/06/2017
Last Update Date: 07/21/2022

Medical Identifiers

Medical identifiers for Sachiko Sweetwood such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1235668963	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
101Y00000X	Counselor	(* (Not Available))	Secondary
103TC0700X	Psychologist - Clinical	PSY30279 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sachiko Sweetwood is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Sachiko Sweetwood, PHD 106 Thorn St, San Diego, CA 92103-5629 Ph: () -	Sachiko Sweetwood, PHD 3252 Holiday Ct Ste 201, La Jolla, CA 92037-1808 Ph: (858) 534-3755

News Archive

Four-year follow-up results from SPRYCEL Phase 3 study in CML-CP presented at ASCO

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced four-year follow-up results from a Phase 3 randomized, open-label, dose-optimization study of SPRYCEL® (dasatinib) in chronic-phase chronic myeloid leukemia (CML-CP) patients resistant or intolerant to Gleevec®* (imatinib mesylate). At four years, for all patients administered SPRYCEL 100 mg once daily, overall survival was 82% (95% CI: 76%-88%) and progression-free survival was 66% (95% CI: 57%-74%).

Boehringer Ingelheim's tiotropium shows promising results in patients with severe persistent asthma

Boehringer Ingelheim today announced data from Phase 2 and Phase 3 studies from the Company's ongoing clinical trial program investigating the efficacy and safety of tiotropium in asthma. These data were presented at the American Thoracic Society International Conference in Philadelphia, Pennsylvania.

Genomic Health to present study results of Oncotype DX multi-gene expression test

Genomic Health, Inc. today announced that the company will present results from two studies at the American Society of Clinical Oncology (ASCO) 2009 Breast Cancer Symposium, taking place October 8 through October 10 at the San Francisco Marriott in San Francisco, California.

Bacterial activity in child's mouth may serve as biomarkers for autism spectrum disorder

New research suggests that shifts in the bacteria within a child's mouth could provide objective biomarkers for identifying autism spectrum disorder.

Sachiko Sweetwood, PHD - Counselor in La Jolla, CA